Gyre Therapeutics Stock Analysis

GYRE Stock   13.47  1.22  9.96%   
Gyre Therapeutics is overvalued with Real Value of 11.02 and Hype Value of 13.39. The main objective of Gyre Therapeutics stock analysis is to determine its intrinsic value, which is an estimate of what Gyre Therapeutics is worth, separate from its market price. There are two main types of Gyre Therapeutics' stock analysis: fundamental analysis and technical analysis.
The Gyre Therapeutics stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Gyre Therapeutics' ongoing operational relationships across important fundamental and technical indicators.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Gyre Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For information on how to trade Gyre Stock refer to our How to Trade Gyre Stock guide.

Gyre Stock Analysis Notes

About 75.0% of the company shares are held by company insiders. The company recorded a loss per share of 1.0. Gyre Therapeutics last dividend was issued on the 12th of January 2023. The entity had 1:15 split on the 31st of October 2023. To learn more about Gyre Therapeutics call Han Ying at 619-949-3681 or check out https://www.gyretx.com.

Gyre Therapeutics Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Gyre Therapeutics' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Gyre Therapeutics or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Gyre Therapeutics had very high historical volatility over the last 90 days
Gyre Therapeutics has high likelihood to experience some financial distress in the next 2 years
Gyre Therapeutics was previously known as Catalyst Biosciences and was traded on NASDAQ Exchange under the symbol CBIO.
The company reported the previous year's revenue of 113.45 M. Net Loss for the year was (85.48 M) with profit before overhead, payroll, taxes, and interest of 0.
About 75.0% of the company shares are held by company insiders
Latest headline from finance.yahoo.com: Why Avidity Biosciences Zoomed to a 12 percent Gain This Week

Gyre Therapeutics Upcoming and Recent Events

4th of April 2024
Upcoming Quarterly Report
View
20th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
4th of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Gyre Largest EPS Surprises

Earnings surprises can significantly impact Gyre Therapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2023-05-04
2023-03-31-0.070.150.22314 
2018-03-01
2017-12-31-1.53-1.250.2818 
2023-10-26
2023-09-30-0.75-1.05-0.340 
View All Earnings Estimates

Gyre Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.14 B.

Gyre Profitablity

The company has Profit Margin (PM) of (0.77) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.13 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.13.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.80)(0.84)
Return On Capital Employed(0.70)(0.73)
Return On Assets(0.80)(0.84)
Return On Equity 5.87  6.17 

Management Efficiency

Gyre Therapeutics has return on total asset (ROA) of 0.1018 % which means that it generated a profit of $0.1018 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8274) %, meaning that it created substantial loss on money invested by shareholders. Gyre Therapeutics' management efficiency ratios could be used to measure how well Gyre Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Equity is expected to grow to 6.17, whereas Return On Tangible Assets are forecasted to decline to (0.84). At present, Gyre Therapeutics' Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 88 M, whereas Intangible Assets are forecasted to decline to about 194.8 K.
Last ReportedProjected for Next Year
Book Value Per Share 0.21  0.22 
Tangible Book Value Per Share 0.21  0.22 
Enterprise Value Over EBITDA 13.21  12.55 
Price Book Value Ratio(98.95)(94.00)
Enterprise Value Multiple 13.21  12.55 
Price Fair Value(98.95)(94.00)
Enterprise Value1.5 B2.2 B
The analysis of Gyre Therapeutics' management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Gyre Therapeutics' future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Gyre Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Operating Margin
0.1293
Profit Margin
(0.77)
Return On Assets
0.1018
Return On Equity
(0.83)

Technical Drivers

As of the 5th of October, Gyre Therapeutics retains the Market Risk Adjusted Performance of 0.1172, risk adjusted performance of 0.0625, and Downside Deviation of 5.92. Gyre Therapeutics technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Gyre Therapeutics variance, value at risk, as well as the relationship between the Value At Risk and skewness to decide if Gyre Therapeutics is priced fairly, providing market reflects its last-minute price of 13.47 per share. Given that Gyre Therapeutics has jensen alpha of 0.003, we strongly advise you to confirm Gyre Therapeutics's regular market performance to make sure the company can sustain itself at a future point.

Gyre Therapeutics Price Movement Analysis

Execute Study
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Gyre Therapeutics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Gyre Therapeutics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Gyre Therapeutics Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Gyre Therapeutics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Gyre Therapeutics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Gyre Therapeutics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Gyre Therapeutics Predictive Daily Indicators

Gyre Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Gyre Therapeutics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Gyre Therapeutics Corporate Filings

F3
6th of September 2024
The schedule filed by any person or group who acquires beneficial ownership of more than 5% of a voting class of a company's equity securities registered under Section 12 of the Act
ViewVerify
F4
16th of August 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
13th of August 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
8K
8th of August 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
12th of July 2024
Other Reports
ViewVerify
8K
5th of July 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify

Gyre Therapeutics Forecast Models

Gyre Therapeutics' time-series forecasting models are one of many Gyre Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Gyre Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Gyre Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Gyre Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Gyre shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Gyre Therapeutics. By using and applying Gyre Stock analysis, traders can create a robust methodology for identifying Gyre entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(0.68)(0.71)
Operating Profit Margin(0.59)(0.62)
Net Loss(0.82)(0.86)
Gross Profit Margin 0.96  1.01 

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Gyre Therapeutics to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Portfolio Diagnostics Now

   

Portfolio Diagnostics

Use generated alerts and portfolio events aggregator to diagnose current holdings
All  Next Launch Module

Complementary Tools for Gyre Stock analysis

When running Gyre Therapeutics' price analysis, check to measure Gyre Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gyre Therapeutics is operating at the current time. Most of Gyre Therapeutics' value examination focuses on studying past and present price action to predict the probability of Gyre Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gyre Therapeutics' price. Additionally, you may evaluate how the addition of Gyre Therapeutics to your portfolios can decrease your overall portfolio volatility.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Global Correlations
Find global opportunities by holding instruments from different markets
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets